- Report
- May 2025
- 100 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- December 2024
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- April 2025
- 50 Pages
North America
From €5287EUR$5,995USD£4,577GBP
- Report
- April 2025
- 66 Pages
Europe
From €5287EUR$5,995USD£4,577GBP
- Report
- April 2025
- 65 Pages
Asia Pacific
From €5287EUR$5,995USD£4,577GBP
- Report
- March 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 186 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- March 2025
- 21 Pages
Canada
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 22 Pages
Australia
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 22 Pages
India
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 22 Pages
Germany
From €4405EUR$4,995USD£3,814GBP
- Report
- June 2021
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- August 2023
- 92 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- March 2025
- 22 Pages
Brazil
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 21 Pages
Mexico
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 22 Pages
Japan
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 23 Pages
China
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 21 Pages
South Korea
From €4405EUR$4,995USD£3,814GBP
- Report
- March 2025
- 21 Pages
Russia
From €4405EUR$4,995USD£3,814GBP

The Hemostasis Device market is a segment of the Medical Devices industry that focuses on the prevention and control of bleeding. Hemostasis Devices are used to stop or slow the flow of blood from a wound or injury. These devices are used in a variety of medical procedures, including surgery, trauma, and vascular access. Hemostasis Devices can be divided into two main categories: mechanical and chemical. Mechanical devices include sutures, staples, and clips, while chemical devices include topical hemostatic agents, such as thrombin and fibrin sealants.
The Hemostasis Device market is driven by the increasing prevalence of chronic diseases, such as cardiovascular diseases, and the growing demand for minimally invasive procedures. Additionally, the development of advanced technologies, such as tissue sealants and hemostatic agents, is expected to drive the market growth.
Some of the major companies in the Hemostasis Device market include Johnson & Johnson, Medtronic, Baxter International, B. Braun Melsungen AG, and C. R. Bard. Show Less Read more